FTEKX yields 14.70% · MRK yields 3.25%● Live data
📍 FTEKX pulled ahead of the other in Year 1
Combined, FTEKX + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FTEKX + MRK for your $10,000?
The investment seeks long-term growth of capital. Normally the fund invests at least 80% of assets in securities of disruptive technology companies. Normally it invests primarily in equity securities. Companies within the disruptive technology theme include but are not limited to those companies that, in the Adviser's opinion, are engaged in big data, machine learning, artificial intelligence, cloud computing/software as a service (SaaS), cybersecurity, ecommerce and consumer technologies, rideshare, and next generation hardware. In pursuing this investment theme, the fund may invest in companies in any economic sector. The fund is non-diversified.
Full FTEKX Calculator →Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.